0001213900-20-026069.txt : 20200910 0001213900-20-026069.hdr.sgml : 20200910 20200910164628 ACCESSION NUMBER: 0001213900-20-026069 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200910 FILED AS OF DATE: 20200910 DATE AS OF CHANGE: 20200910 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Aberman Zami CENTRAL INDEX KEY: 0001344740 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31392 FILM NUMBER: 201169095 MAIL ADDRESS: STREET 1: 63 RABUTZKY STREET CITY: RAANANA STATE: L3 ZIP: 43220 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PLURISTEM THERAPEUTICS INC CENTRAL INDEX KEY: 0001158780 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 980351734 STATE OF INCORPORATION: NV FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: MATAM ADVANCED TECHNOLOGY PARK STREET 2: BUILDING NO. 5 CITY: HAIFA STATE: L3 ZIP: 3508409 BUSINESS PHONE: 972-74-710-7171 MAIL ADDRESS: STREET 1: MATAM ADVANCED TECHNOLOGY PARK STREET 2: BUILDING NO. 5 CITY: HAIFA STATE: L3 ZIP: 3508409 FORMER COMPANY: FORMER CONFORMED NAME: PLURISTEM LIFE SYSTEMS INC DATE OF NAME CHANGE: 20030701 FORMER COMPANY: FORMER CONFORMED NAME: AI SOFTWARE INC DATE OF NAME CHANGE: 20010906 4 1 ownership.xml OWNERSHIP DOCUMENT X0306 4 2020-09-10 0 0001158780 PLURISTEM THERAPEUTICS INC PSTI 0001344740 Aberman Zami MATAM PARK, BUILDING #5 HAIFA L3 3508409 ISRAEL 1 1 0 0 Executive Chairman Restricted Stock Units 2020-09-10 4 A 0 500000 0 A 993973 D Restricted Stock Units 2020-09-10 4 A 0 500000 0 A 1493973 D Common Stock 11140 I By Rose Hitech Ltd. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The shares vest over four years as follows: 12.5% shall vest on the 6 month anniversary of the date of grant and the remaining shares vest in 14 equal installments every 3 months thereafter. The shares vest in full upon milestone achievement of increasing market capitalization of the Issuer's common stock on the Nasdaq Capital Market to $550 million within no more than 3 years from the date of grant. Such number of shares of common stock have been adjusted to reflect the reverse stock split that occurred on July 25, 2019. /s/ Zami Aberman 2020-09-10